
Deborah Crouch
Examiner (ID: 19500, Phone: (571)272-0727 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 3725, 1819, 1632, 2899, 1804 |
| Total Applications | 1439 |
| Issued Applications | 694 |
| Pending Applications | 237 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5485737
[patent_doc_number] => 20090275502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING DEVELOPMENTAL POTENTIAL OF OOCYTES AND PREIMPLANTATION EMBRYOS'
[patent_app_type] => utility
[patent_app_number] => 11/917675
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25117
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917675 | METHODS AND COMPOSITIONS FOR ENHANCING DEVELOPMENTAL POTENTIAL OF OOCYTES AND PREIMPLANTATION EMBRYOS | Jun 15, 2006 | Abandoned |
Array
(
[id] => 5627263
[patent_doc_number] => 20060265768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Breeding and milking cows for milk free of beta-casein A1'
[patent_app_type] => utility
[patent_app_number] => 11/439114
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15525
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20060265768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11439114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/439114 | Breeding and milking cows for milk free of β-casein A1 | May 23, 2006 | Issued |
Array
(
[id] => 8796919
[patent_doc_number] => 08435787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Alginate polyelectrolyte encapsulation of embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/919407
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10052
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11919407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919407 | Alginate polyelectrolyte encapsulation of embryonic stem cells | May 8, 2006 | Issued |
Array
(
[id] => 5243988
[patent_doc_number] => 20070022483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Transgenic animal model for Alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/413873
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2710
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20070022483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413873 | Tau hyperphosphorylation in transgenic mice expressing the APP double mutation | Apr 27, 2006 | Issued |
Array
(
[id] => 5409532
[patent_doc_number] => 20090123430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'METHOD FOR DIFFERENTIATION OF STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/817652
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9302
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123430.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817652 | Culture of mammalian pluripotent stem cells in the presence of hyaluronan induces differentiation into multi-lineage progenitor cells | Mar 2, 2006 | Issued |
Array
(
[id] => 5649047
[patent_doc_number] => 20060134782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Differentiated cells suitable for human therapy'
[patent_app_type] => utility
[patent_app_number] => 11/359341
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26845
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134782.pdf
[firstpage_image] =>[orig_patent_app_number] => 11359341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/359341 | In vitro differentiated cell and human embryonic stem cell population | Feb 20, 2006 | Issued |
Array
(
[id] => 5619439
[patent_doc_number] => 20060188972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Targeted modification of chromatin structure'
[patent_app_type] => utility
[patent_app_number] => 11/357615
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30063
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357615
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357615 | Targeted modification of chromatin structure | Feb 15, 2006 | Abandoned |
Array
(
[id] => 5661466
[patent_doc_number] => 20060252062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'System and process for genetic and epigenetic treatment'
[patent_app_type] => utility
[patent_app_number] => 11/352299
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8704
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352299 | System and process for genetic and epigenetic treatment | Feb 12, 2006 | Abandoned |
Array
(
[id] => 4476715
[patent_doc_number] => 07906330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Two cell population comprising chondrocyte precursors and human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/345878
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8007
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906330.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345878 | Two cell population comprising chondrocyte precursors and human embryonic stem cells | Jan 31, 2006 | Issued |
Array
(
[id] => 5342341
[patent_doc_number] => 20090180991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA'
[patent_app_type] => utility
[patent_app_number] => 11/815294
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10846
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20090180991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815294
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815294 | Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia | Jan 30, 2006 | Issued |
Array
(
[id] => 5778700
[patent_doc_number] => 20060107340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto'
[patent_app_type] => utility
[patent_app_number] => 11/329010
[patent_app_country] => US
[patent_app_date] => 2006-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23348
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20060107340.pdf
[firstpage_image] =>[orig_patent_app_number] => 11329010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/329010 | Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto | Jan 7, 2006 | Abandoned |
Array
(
[id] => 52810
[patent_doc_number] => 07772001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Directed differentiation of embryonic stem cells into an endoderm cell'
[patent_app_type] => utility
[patent_app_number] => 11/322523
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 8511
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322523 | Directed differentiation of embryonic stem cells into an endoderm cell | Jan 2, 2006 | Issued |
Array
(
[id] => 4886390
[patent_doc_number] => 20080260722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Method for High Efficiency Survival/Proliferation of Human Embyonic Stem Cells and Human Embryo Survival in Culture'
[patent_app_type] => utility
[patent_app_number] => 11/794455
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15704
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260722.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794455
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794455 | Method for High Efficiency Survival/Proliferation of Human Embyonic Stem Cells and Human Embryo Survival in Culture | Dec 29, 2005 | Abandoned |
Array
(
[id] => 5666581
[patent_doc_number] => 20060171931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Methods and compositions for modulating stem cell growth and differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/318419
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28112
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11318419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/318419 | Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling | Dec 21, 2005 | Issued |
Array
(
[id] => 5865054
[patent_doc_number] => 20060099184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors'
[patent_app_type] => utility
[patent_app_number] => 11/303896
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15923
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303896 | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5865055
[patent_doc_number] => 20060099185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Methods of treating anemia using recombinant adeno-associated virus virions'
[patent_app_type] => utility
[patent_app_number] => 11/305629
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16501
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099185.pdf
[firstpage_image] =>[orig_patent_app_number] => 11305629
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/305629 | Methods of treating anemia using recombinant adeno-associated virus virions | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5742787
[patent_doc_number] => 20060088512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Treatment of T cell disorders'
[patent_app_type] => utility
[patent_app_number] => 11/296676
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15342
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296676 | Treatment of T cell disorders | Dec 6, 2005 | Abandoned |
Array
(
[id] => 352844
[patent_doc_number] => 07491867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates'
[patent_app_type] => utility
[patent_app_number] => 11/291668
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 44
[patent_no_of_words] => 31439
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491867.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291668 | Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates | Nov 30, 2005 | Issued |
Array
(
[id] => 5615465
[patent_doc_number] => 20060117395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates'
[patent_app_type] => utility
[patent_app_number] => 11/292164
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 31478
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20060117395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292164
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292164 | Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5847780
[patent_doc_number] => 20060123503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto'
[patent_app_type] => utility
[patent_app_number] => 11/285580
[patent_app_country] => US
[patent_app_date] => 2005-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32814
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20060123503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285580 | V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto | Nov 20, 2005 | Abandoned |